The Association of Innovative Pharmaceutical Industry (AIFP) associates 35 pharmaceutical companies that operate in the Czech Republic and develop and market new, more effective and safer medicinal products.
AbbVie may have been founded in 2013, but its roots run deep. In 2013, it became a separate company from Abbott. Its name represents its connection to the past and the future. When AbbVie became a separate company, it formed a new kind of enterprise—a biopharmaceutical company. AbbVie blends the stability, global scale, resources and commercial capabilities of a pharmaceutical company with the focus and culture of a biotech. Today,…
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives are at stake. Alexion has 2,500 passionate and dedicated employees serving patients in 50 countries around the world.
Amgen i sone of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and Innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
Astellas was established in 2005 through merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. The Astellas Group’s business philosophy has three elements — raison d'être, mission and beliefs.
AstraZeneca is a global, science-led biopharmaceutical business and its innovative medicines are used by millions of patients worldwide. It is focused on returning to growth through science-led innovation.
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With its innovative products, it is contributing to finding solutions to some of the major challenges of our time.
Berlin-chemie is a German subsidiary of the MENARINI Group, which has been occupying a leading position in the Italian pharmaceutical market for many years. The company, which was formed in 1886 and is headquartered in Florence, was developed over the generations to become a global, owner-managed pharmaceutical company.
Since its founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. The focus in doing so is on diseases for which no satisfactory treatment option exists to date.
Bristol-Myers Squibb is a differentiated company, led by its unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm.
Celgene seeks to deliver truly innovative and life-changing drugs for patients. Its vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
Eisai is a leading global research and development-based pharmaceutical company headquartered in Japan. Established in 1941, Eisai is a pharmaceutical company operating globally in terms of R&D, manufacturing, distribution and marketing, with a strong focus on prescription medicines.
Eli Lilly was founded in 1876 by Colonel Eli Lilly. Three long established core values guide Lilly – integrity, excellence and respect for people. Lilly unites caring with discovery to create medicines that make life better for people around the world.
GSK is a science-led global healthcare company, beginning in 1715 with the opening of an apothecary shop in London. It has 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
Ipsen is a global biopharmaceutical group dedicated to improving lives through innovative medicines in Oncology, Neuroscience and Rare Diseases. It also has a well-established and successful Consumer Healthcare business. Ipsen is committed to discovering new solutions for targeting debilitating diseases and improving the quality of life for patients.
Janssen was founded in 1953 by Paul Janssen in Beerse, Belgium. Janssen is developing treatments for patients in six important therapeutic areas of healthcare – cardiovascular & metabolism, immunology, infectious diseases & vaccines, neuroscience, oncology, pulmonary hypertension.
Kyowa Hakko Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Hakko Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.
Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company. LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally.
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at the disease areas depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.
The company is known as Merck in the United States and Canada. Everywhere else, i tis known as MSD. MSD is an innovative, global healthcare leader that is committed to improving health and well-being around the world. Its core product categories include diabetes, cancer, vaccines and hospital acute care.
Founded in 1668 in Darmstadt, Germany, Merck is the world's oldest pharmaceutical and chemical company. Since 1668, Merck has developed from a small pharmacy into a leading science and technology company. It invests substantial amounts in developing new therapies and medical technologies – for instance against cancer and chronic progressive diseases, especially those of the immune system, including multiple sclerosis (MS).
The Mundipharma global network of independent associated companies, founded in the US by two physicians in 1952, shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe.
Novartis provides healthcare solutions that address the evolving needs of patients and societies worldwide. Its broad portfolio includes innovative pharmaceuticals and oncology medicines, generic and biosimilar medicines and eye care devices.
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given Novo Nordisk experience and capabilities that also enable it to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
Pfizer is an American pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut. The company develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology.
The laboratory was established in the early 1960s by Pierre Fabre, a pharmacist in Castres, France. For the past 50 years, the company has pursued a development strategy focusing on the needs of patients. The Pierre Fabre group bases their approach on the complementarity of their activity fields: drugs, health products and dermo-cosmetic products.
The company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. Roche was one of the first companies to bring targeted treatments to patients, it is world's number 1 in biotech with 17 biopharmaceuticals on the market.
Sanofi, founded in 1973, it is a French global pharmaceutical company headquartered in Paris, France. The company covers seven major therapeutic areas: diabetes and cardiovascular diseases, oncology, immunology, multiple sclerosis, rare diseases, vaccines.
As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries.
Servier is an international pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France. Since opening its first laboratory in 1954, it has been committed to therapeutic progress to serve patient needs with the help of healthcare professionals.
Stallergenes Greer is a global healthcare company specializing in the diagnosis and treatment of allergies through the development and commercialization of allergy immunotherapy (AIT) products and services.
Takeda is a R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Takeda‘s R&D efforts are focused on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience and Rare Diseases. Takeda also makes targeted R&D investments in Plasma-Derived Therapies and Vaccines.
UCB is a global biopharmaceutical company that was founded in 1928 in Brussels by Emmanuel Janssen. UCB’s ambition is to transform the lives of people living with severe diseases. It focuses on neurology and immunology disorders.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. It discovered and developed the first medicines to treat the underlying cause of cystic fibrosis. In addition to clinical development programs in this therapeutic area, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other…